Pharmaceutical

CT-7439 by Carrick Therapeutics for Breast Cancer: Likelihood of Approval

CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase I for Breast Cancer.

Dec 31, 2024 - 06:00
CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase I for Breast Cancer.
Read the original article

Tags:

Previous Article

Iptacopan hydrochloride by Novartis for Granulomatosis with Polyangiitis (Wegene...

Next Article

ITM-91 by ITM Isotope Technologies Munich for Metastatic Colorectal Cancer: Like...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Allink Biotherapeutics secures funding to advance ADC pipeline

Allink Biotherapeutics secures funding to advance ADC p...

Nov 29, 2024

MBX-1416 by MBX Biosciences Inc for Hypoglycemia: Likel...

Nov 4, 2023

Opinion: The misguided reason why providers aren’t prescribing more buprenorphine for opioid use disorder

Opinion: The misguided reason why providers aren’t pres...

Jan 6, 2024